NKGen Biotech, Inc. - NKGN Sotuvning sof marjinal rentabelligi

NKGen Biotech Inc (NKGN) tovar belgisi

NKGen Biotech, Inc. (NKGN) neyrotadqiqotlar sohasida bioetik standartlarni va energiyaning samaradorligini joriy qilmoqda. GURU.Markets tizimi sof foydaga asoslangan sotuv samaradorligi ko'rsatkichini taqdim etadi, bunda 0.00 qiymati ushbu ko'rsatkichning balansini aks ettiradi. NKGen Biotech, Inc. (NKGN) Altsgeymer kasalligiga qarshi kurashish uchun noyob NK-hujayra terapiyasi tarmog'ini ishlab chiqmoqda, garchi hozirda biznes faqat operatsion daromad manbalarisiz naqd pul sarfi bilan xarakterlanayotgan bo'lsa-da.

NKGen Biotech Corp (NKGN) - Sof foyda bo'yicha sotuv rentabelligi 21.02.2024dan 15.03.2025gacha

NKGen (NKGN) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning barcha koʻrsatkichlari tahlili:NKGen Biotech, Inc.
NKGen Biotech Inc tayyor mahsulotlari

NKGen Biotech, Inc. (NKGN) daromadlari neyrodegeneratsiyaga qarshi kurashish uchun NK-hujayralariga asoslangan terapiyaning muvaffaqiyatli tijoratlashtirilishiga bog'liq. 0.00 ga teng bo'lgan sof foyda marjasi har bir dollar daromadning qancha qismi sof foydaga aylanishini belgilaydi. Ushbu ko'rsatkichning o'sishi operatsion modelning samaradorligini va rivojlanishning kengayish imkoniyatlarini tasdiqlaydi. Biroq, bir martalik hisobdan chiqarishlar biznesning haqiqiy daromadliligini vaqtincha buzishi mumkin. Sof foyda marjasi tendentsiyasini tahlil qilish orqali investor aktivning fundamental qiymati barqarorligini baholaydi.

Muhim raqobatchilar

BIIB: Sotuvning sof marjinal rentabelligi|Sof marja Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Sotuvning sof marjinal rentabelligi|AXSM: Sof foyda normasi|Sof marja acadia-pharm.com (ACAD)|Sotuvning sof marjinal rentabelligi Xenon Pharmaceuticals (XENE)|Sof marja Viking Therapeutics VKTX|Sof foyda normasi SUPN|CPRX - Sof marja|Sof marja Denali Therapeutics|HRMY: Sotuvning sof marjinal rentabelligi|Biohaven - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi AMLX|Trevi Therapeutics, Inc. (TRVI) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi PRAX (Praxis Medicines)|Anavex Corp - Sotuvning sof rentabelligi|Sof marja CeriBell CBLL|Kompaniya sotuv marjasi Prothena Biosciences (PRTA)|ALEC: Sof foyda bo'yicha sotuv rentabelligi|ANNX - Sotuvning sof marjinal rentabelligi|Omeros Corp. (OMER) - Sof marja|Sof marja Neurogene Inc. (NGNE)|Sof foyda bo'yicha sotuv rentabelligi ACIU|Sof marja VYGR|Sof marja Neumora (NMRA)|SCLX - Sof marja|Sotuvning sof marjinal rentabelligi TVGN (Tevogen Bio Holdings Inc.)|Sof foyda normasi ACOG|Cognition Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|IKT - Sotuvning sof marjinal rentabelligi|SAVA: Sotuvning sof marjinal rentabelligi|Assertio Holdings, Inc. - Sof foyda normasi|COYA (Coya) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi VTGN (Vistagen Therapeutics)|Sof marja Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning sof rentabelligi|Sof marja CervoMed, Inc. CRVO|Sotuvning sof marjinal rentabelligi Alterity Therapeutics ATHE|CLNN: Sof foyda bo'yicha sotuv rentabelligi|PEPG (pepgen.com) - Sotuvning sof rentabelligi|Jupiter Neurosciences Inc (JUNS) - Sof marja|Relmada Therapeutics - Sof foyda normasi|ANVS (Annovis Bio Inc) - Sotuvning sof marjinal rentabelligi|GRCE: Sof foyda normasi|Sof marja Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Sof foyda normasi|Sof marja neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Sof marja|MTVA: Sof foyda bo'yicha sotuv rentabelligi|NeurAxis, Inc (NRXS) - Sof foyda bo'yicha sotuv rentabelligi|HSDT: Sotuvning sof marjinal rentabelligi|PASG - Kompaniya sotuv marjasi|Sof marja Neuphoria Therapeutics, Inc.|Sof marja NERV|Sotuvning sof marjinal rentabelligi ATHA|ADXN (Addex Therapeutics Ltd) - Sof foyda normasi|Sof marja alzamend.com ALZN|Kompaniya sotuv marjasi Cyclerion Therapeutics (CYCN)|Protagenic - Sotuvning sof marjinal rentabelligi|Sof foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Sotuvning sof marjinal rentabelligi|Avenue Therapeutics Inc. (ATXI) - Sotuvning sof marjinal rentabelligi|BCLI (BrainStorm Cell Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi Cara Therapeutics Inc|Sof marja Chromocell Therapeutics (CHRO)|Kompaniyaning sof rentabelligi ELYM|Sof marja Intra-Cellular ITCI|LBPH: Sotuvning sof rentabelligi|MRNS - Sof marja|Sof foyda normasi NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi SNPX|Sof foyda bo'yicha sotuv rentabelligi TRVN|Sof marja VIGL|Sotuvning sof marjinal rentabelligi WENA|Kompaniya sotuv marjasi Cerevel